Amgen Inc (AMGN)

206.10
+4.50(+2.23%)
  • Volume:
    2,672
  • Bid/Ask:
    206.10/206.50
  • Day's Range:
    200.35 - 206.20
  • Type:Equity
  • Market:Germany
  • ISIN:US0311621009
  • WKN:867900

AMGN Overview

Prev. Close
201.6
Day's Range
200.35-206.2
Revenue
-
Open
201.45
52 wk Range
173.92-222.55
EPS
-
Volume
2,672
Market Cap
116.12B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,119
P/E Ratio
-
Beta
-
1-Year Change
1.5%
Shares Outstanding
563,265,902
Next Earnings Date
-
What is your sentiment on Amgen Inc?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc Company Profile

Employees
24300

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.